Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The molecular genetics of RASopathies: An update on novel disease genes and new disorders. | Am J Med Genet C Semin Med Genet | 2022 | 36394128 | PubTator, text mining | PubMed |
| The role of KRAS splice variants in cancer biology. | Front Cell Dev Biol | 2022 | 36393833 | PubTator, text mining | PubMed |
| Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts. | Sci Rep | 2022 | 36369472 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors and RAS-ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma. | Biomolecules | 2022 | 36358912 | PubTator, text mining | PubMed |
| The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets. | Cancers (Basel) | 2022 | 36358725 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease between Proliferation and Neoplasia. | Cancers (Basel) | 2022 | 36358690 | PubTator, text mining | PubMed |
| A Whole New Comprehension about ncRNA-Encoded Peptides/Proteins in Cancers. | Cancers (Basel) | 2022 | 36358616 | PubTator, text mining | PubMed |
Predicting Deleterious Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) of HRAS Gene and In Silico Evaluation of Their Structural and Functional Consequences towards Diagnosis and Prognosis of Cancer. | Biology (Basel) | 2022 | 36358305 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
| RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation. | Mol Cell | 2022 | 36347258 | PubTator, text mining | PubMed |
| Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa. | BMC Cancer | 2022 | 36344948 | PubTator, text mining | PubMed |
| Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer. | NPJ Breast Cancer | 2022 | 36333333 | PubTator, text mining | PubMed |
| Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis. | Int J Oncol | 2022 | 36321791 | PubTator, text mining | PubMed |
| Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. | Mol Cancer | 2022 | 36320056 | PubTator, text mining | PubMed |
| Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data. | BMC Cancer | 2022 | 36316649 | PubTator, text mining | PubMed |
| Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. | EMBO J | 2022 | 36314681 | PubTator, text mining | PubMed |
| Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature. | Front Pediatr | 2022 | 36313893 | PubTator, text mining | PubMed |
| Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma. | Cold Spring Harb Mol Case Stud | 2022 | 36307212 | PubTator, text mining | PubMed |
| Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. | Cell Death Dis | 2022 | 36302755 | PubTator, text mining | PubMed |
| The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms. | Int J Mol Sci | 2022 | 36293054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=18